| Title |
Olanzapine in long‐term treatment for bipolar disorder
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2009
|
| DOI | 10.1002/14651858.cd004367.pub2 |
| Pubmed ID | |
| Authors |
Andrea Cipriani, Jennifer M Rendell, John Geddes |
| Abstract |
Many patients with bipolar disorder require long-term treatment to prevent recurrence. Antipsychotic drugs are often used to treat acute manic episodes. It is important to clarify whether olanzapine could have a role in long-term prevention of manic and depressive relapses. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 243 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Australia | 1 | <1% |
| Brazil | 1 | <1% |
| India | 1 | <1% |
| Canada | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 237 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 33 | 14% |
| Student > Bachelor | 30 | 12% |
| Student > Master | 26 | 11% |
| Student > Doctoral Student | 15 | 6% |
| Student > Ph. D. Student | 14 | 6% |
| Other | 52 | 21% |
| Unknown | 73 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 81 | 33% |
| Psychology | 27 | 11% |
| Nursing and Health Professions | 13 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 5% |
| Unspecified | 7 | 3% |
| Other | 29 | 12% |
| Unknown | 74 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 March 2024.
All research outputs
#6,782,944
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#7,921
of 11,499 outputs
Outputs of similar age
#43,105
of 184,852 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 83 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 184,852 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 83 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.